Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Schizophrenia, Antipsychotic Treatment and the Risk for Diabetes Mellitus

NCT00222807 is registered in ClinicalTrials.gov with University of Pittsburgh as lead sponsor.

NCT NCT00222807
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00222807 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Schizophrenia, Antipsychotic Treatment and the Risk for Diabetes Mellitus
Lead sponsor
University of Pittsburgh
Phase
Observational
Overall status
Completed
Start date
August 31, 2003
Completion date
March 31, 2016
Enrollment
200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

delusional disorder, schizoaffective disorder, schizophrenia